Abstract
Objective
The B-cell lymphoma/leukemia 11A (BCL11A) gene is essential for normal lymphoid development and has been associated with hematological malignancies. In the current study, the relative expression level of BCL11A in malignant hematological cell lines was evaluated through real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR).
Methods
The relative expression level of BCL11A mRNA in malignant hematological cell lines was determined through qRTPCR using SYBR Green I dye. Glyceraldehyde-3-phosphate dehydrogenase was used as the reference gene to confirm the relative expression level of BCL11A gene mRNA.
Results
The relative expression level of BCL11A mRNA in cell lines from B-cell malignancies was significantly higher compared with that from acute myeloid leukemia (P < 0.05). Different cell lines with malignant B-cells exhibited a wide range of BCL11A expressions ranging from 27.37 to 93.38.
Conclusion
The overexpression of BCL11A gene mRNA in malignant B-cells might play a role in B-cell lymphoma/leukemia.
Similar content being viewed by others
References
Liu P, Keller JR, Ortiz M, et al. Bcl11a is essential for normal lymphoid development. Nat Immunol 2003; 4: 525–532.
Li L, Leid M, Rothenberg EV. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 2010; 329: 89–93.
Huang X, Chen S, Shen Q, et al. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematolo Oncol 2010; 3: 44.
Karlsson A, Nordigården A, Jönsson JI, et al. Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells. BMC Cancer 2007; 7: 195
Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, et al. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B — cell protooncogene product. Mol Cell Biol 2000; 20: 3178–3186.
Hystad ME, Myklebust JH, Bø TH, et al. Characterization of early stages of human B cell development by gene expression profiling. J Immunol 2007; 179: 3662–3671.
Liu H, Ippolito CG, Wall KJ, et al. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Molecular Cancer 2006; 5; 18.
Satterwhite E, Sonoki T, Willis TG, et al. The BCL11 genefamily: involvement of BCL 1 1 A in lymphoid malignancies. Blood 2001; 98: 3413–3420.
Weniger MA, Pulford K, Gesk S, et al. Gains of the protooncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 2006; 20: 1880–1882.
Martín-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474–1477.
Yin B, Delwel R, Valk PJ, et al. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood 2009; 113: 1075–1085.
Gao YJ, He DM, Chen SH, et al. Quantitative detection of BCL11A gene expression in B cell malignancies by real-time RT-PCR. Jinan Daxue Xuebao 2011; 32: 147–150 (Chinese)
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.
Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in realtime PCR. Nucleic Acids Res 2002; 30: e36.
Xu J, Sankaran VG, Ni M, Menne TF, et al. Transcriptional silencing of {gamma}-globin by BCL11A involves longrange interactions and cooperation with SOX6. Genes Dev 2010; 24: 783–798.
Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005; 106: 3183–3190.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Gao, Yj., He, Dm., Chen, Sh. et al. Expression of the B-cell lymphoma/leukemia 11A gene in malignant hematological cell lines through quantitative reverse transcription polymerase chain reaction. Clin. Oncol. Cancer Res. 8, 242–246 (2011). https://doi.org/10.1007/s11805-011-0588-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11805-011-0588-2